Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Mar;61(3):395-403.
doi: 10.1053/j.ajkd.2012.10.018. Epub 2012 Dec 8.

Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study

Rikki M Tanner  1 , Orlando M Gutiérrez, Suzanne Judd, William McClellan, C Barrett Bowling, Brian D Bradbury, Monika M Safford, Mary Cushman, David Warnock, Paul Muntner
Affiliations
Comparative Study

Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study

Rikki M Tanner et al. Am J Kidney Dis. 2013 Mar.

Abstract

Background: It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States.

Study design: Cross-sectional and ecologic.

Setting & participants: White (n = 16,410) and black (n = 11,109) participants from across the continental United States in the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Predictor: Geographic region, defined by the 18 networks of the US ESRD Network Program.

Outcomes & measurements: Albuminuria, defined as albumin-creatinine ratio ≥30 mg/g, and decreased estimated glomerular filtration rate (eGFR), defined as <60 mL/min/1.73 m(2), were measured in the REGARDS Study. ESRD incidence rates were obtained from the US Renal Data System.

Results: For whites, the network-specific prevalence of albuminuria ranged from 8.4% (95% CI, 3.3%-13.5%) in Network 15 to 14.8% (95% CI, 8.0%-21.6%) in Network 3, and decreased eGFR ranged from 4.3% (95% CI, 2.0%-6.6%) in Network 4 to 16.7% (95% CI, 12.7%-20.7%) in Network 7. For blacks, the prevalence of albuminuria ranged from 12.1% (95% CI, 8.7%-15.5%) in Network 5 to 26.5% (95% CI, 16.7%-36.3%) in Network 4, and decreased eGFR ranged from 6.7% (95% CI, 5.0%-8.4%) in Network 17/18 to 13.4% (95% CI, 7.8%-19.1%) in Network 12. Spearman correlation coefficients for the prevalence of albuminuria and decreased eGFR with network-specific ESRD incidence rates were 0.49 and 0.24, respectively, for whites and 0.29 and 0.25, respectively, for blacks.

Limitations: There were few cases of albuminuria and decreased eGFR in some geographic regions.

Conclusions: In the United States, substantial geographic variations in the prevalence of albuminuria and decreased eGFR exist, but were correlated only modestly with ESRD incidence, suggesting the chronic kidney disease burden may not explain the geographic variation in ESRD incidence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
End-stage renal disease incidence rates per million population in 2005 by end-stage renal disease network among whites (left) and blacks (right) ≥45 years. The table is limited to the continental US as the REGARDS study did not recruit participants from Alaska, Hawaii, or US protectorates.
Figure 2
Figure 2
Prevalence of albuminuria† (left), reduced estimated glomerular filtration rate (eGFR; center)‡, and both albuminuria/reduced eGFR (right) by end-stage renal disease network of residence among white (top panel) and blacks (bottom panel) REGARDS participants. N/A: Estimates not shown due to insufficient sample size (n<50) for blacks in these regions. Prevalence is weighted to represent the US population. † Albuminuria defined as albumin-to-creatinine ratio (ACR) ≥30 mg/g ‡ Reduced eGFR defined as levels <60 mL/min/1.73m2
Figure 3
Figure 3
Correlation of end-stage renal disease network-specific prevalence of albuminuria† (left), reduced estimated glomerular filtration rate‡ (center), and both albuminuria/reduced eGFR (right) among REGARDS participants with USRDS-derived end-stage renal disease incidence rates for whites (top panel) and blacks (bottom panel). r= Spearman correlation coefficient †Albuminuria defined as an albumin to creatinine ratio ≥30 mg/g ‡Reduced eGFR defined as levels <60 ml/min/1.73m2 Networks 15 and 16 excluded for blacks due to small sample size (n<50) for blacks in these regions
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA : the journal of the American Medical Association. 2007 Nov 7;298(17):2038–2047. - PubMed
    1. USRDS. USRDS 2004 annual data report: atlas of end-stage renal disease in the United States. 2004 - PubMed
    1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England journal of medicine. 2004 Sep 23;351(13):1296–1305. - PubMed
    1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Archives of internal medicine. 2004 Mar 22;164(6):659–663. - PubMed
    1. [Accessed August 8, 2011];Renal Data Extraction and Referencing System. http://www.usrds.org/odr/xrender_home.asp.

Publication types

MeSH terms

-